- Patent Title: Methods and monitoring of treatment with a WNT pathway inhibitor
-
Application No.: US15147521Application Date: 2016-05-05
-
Publication No.: US09987357B2Publication Date: 2018-06-05
- Inventor: Jakob Dupont , Robert J. Stagg
- Applicant: OncoMed Pharmaceuticals, Inc.
- Applicant Address: US CA Redwood City
- Assignee: OncoMed Pharmaceuticals, Inc.
- Current Assignee: OncoMed Pharmaceuticals, Inc.
- Current Assignee Address: US CA Redwood City
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A61K38/17
- IPC: A61K38/17 ; G01N33/68 ; A61K39/395 ; C07K16/30 ; A61K31/675 ; C07K16/28 ; A61K45/06 ; G01N33/574 ; A61K39/00 ; C07K14/72
Abstract:
Methods for treating diseases such as cancer comprising administering a Wnt pathway inhibitor, either alone or in combination with other anti-cancer agents, and monitoring for skeletal-related side effects and/or toxicity.
Public/Granted literature
- US20160346388A1 Methods and Monitoring of Treatment With A WNT Pathway Inhibitor Public/Granted day:2016-12-01
Information query
IPC分类:
